Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

7,150 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Sklamberg Discusses Cannabis Rescheduling On NPR's 1A Podcast

    Howard Sklamberg, Life Sciences & Healthcare Regulatory partner and former FDA Deputy Commissioner, was recently a guest on NPR's podcast 1A for its episode...
    United StatesCannabis & Hemp
    Arnold & Porter
    Arnold & Porter
  • Video

    Compliance Issues For Global Life Sciences Companies (Video)

    Kim Nemirow, Ropes & Gray government enforcement partner, analyzes new compliance strategies global life sciences companies are facing in an evolving market.
    United StatesCorporate/Commercial Law
    Ropes & Gray LLP
    Ropes & Gray LLP
Article

Legal Guide To Private Equity, "§32 Biotechnology Investments"

In this chapter, co-authored with Adrian M. Schell, Dr. Freier examines the key legal issues surrounding private equity investments in the biotech/pharma industry.
United StatesCorporate/Commercial Law
Arnold & Porter
Arnold & Porter
  • Article

    How Life Science Employers Can Ensure Restrictive Covenants Survive A Restructuring

    How Life Science Employers Can Ensure Restrictive Covenants Survive a Restructuring
    United StatesEmployment and HR
    Fisher Phillips LLP
    Fisher Phillips LLP
  • Article

    'Life Science Success' Podcast

    Cooley partner Josh Seidenfeld discusses past experiences with small companies and startups, his life sciences practice and more in an installment of "Life Science Success," a weekly podcast series...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Cooley LLP
    Cooley LLP
  • Article

    'Voracious Consumers Of Capital': How The Life Sciences Boom Is Fueling Law Firm Business

    "Life sciences work – across transactions, intellectual property and regulatory matters – provided a bright spot in Big Law business in 2020 that firms expect to fuel an even more promising 2021."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Cooley LLP
    Cooley LLP
  • Article

    2020 Enforcement Review: FDA-Regulated Medical Products And Food Safety

    The dynamic nature of the COVID-19 pandemic demanded an all-hands-on-deck approach to enforcement in 2020 by the U.S. Food and Drug Administration ("FDA"),
    United StatesFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    A Comparison Of The U.S. And French Sunshine Reporting Requirements

    This past year both the U.S. and France enacted substantial new reporting and disclosure requirements under their respective Sunshine Acts.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    A Look Ahead In Life Sciences: What We Are Tracking In Q2 2024 And Beyond

    As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so does the legal, regulatory, and compliance landscape.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    A Look Ahead In Life Sciences: What We Are Tracking In Q3 2023 And Beyond

    As the life sciences industry continues to expand and grow increasingly complex, so does its legal, regulatory, and compliance landscape.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    AbbVie And Novartis Announce Billion Dollar Licensing Deals For Oncology And Alzheimer's Treatments

    On January 12, 2026, AbbVie and RemeGen announced an exclusive licensing agreement granting AbbVie rights to develop, manufacture, and commercialize RemeGen's RC148 outside of Greater China.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Academic Physician Compensation Plans Take a New "Curve" Towards Performance Incentives

    Over the last several years, there has been a trend on the part of Academic Medical Centers (AMCs) to adopt more performance incentive-based faculty compensation plans for their physicians.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    Agricultural Research Service Increases Patent Culture Collection Charges

    ARS's Patent Culture Collection receives about 120 patent deposits per year and distributes about 450 cultures per year.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Aligning United States Core Childhood Vaccine Recommendations With Best Practices From Peer, Developed Countries (Trump EO Tracker)

    This memorandum directs the Secretary of Health and Human Services and the Director of the Centers for Disease Control and Prevention to review best practices from peer...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Akin
    Akin
  • Article

    Alteogen Seeks Approval For Aflibercept Biosimilar In Korea

    On September 13, 2024, Alteogen announced that it has applied for marketing authorization in Korea for ALT-L9, an aflibercept biosimilar of EYLEA®.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    APHIS Deregulates African Marigold Engineered To Produce Red Flowers

    The USDA's Animal and Plant Health Inspection Service has made a regulatory determination regarding a genetically engineered African marigold variety developed to produce red flower petals. This decision follows evaluation of scientific data, plant pest risk assessments, and public comments regarding the modified ornamental plant's regulatory status under federal biotechnology regulations.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Bergeson & Campbell
    Bergeson & Campbell
  • Article

    APHIS Notifies Petition To Amend Reporting Requirements For Research Facilities Under Animal Welfare Act Regulations

    The petition is available to the public, and APHIS is soliciting comments.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    APHIS Proposes To Amend The National Poultry Improvement Plan And Regulations

    These changes aim to align the regulations with international standards and make them more transparent.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    APHIS Reopens Comment Period To Amend Animal Welfare Act Regulations

    In the July 24, 2015, Federal Register, USDA's APHIS reopened the comment period of a proposal.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    APHIS Solicits Comments On Petition To Develop Specific Ethologically Appropriate Standards For Nonhuman Primates In Research

    In the May 1, 2015, Federal Register, APHIS announced receipt of a petition requesting to amend regulations to specify ethologically appropriate standards researchers must adhere to...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Showing 61–80 of 7150 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics